Sparebank 1 SMN (0IVM)
London Exchange · UK · prices in NOK · close of 23 Oct 2026
Key indicators
| Last close | NOK 214.35 |
|---|---|
| 52-week range | 182.12 – 221.73 |
| Return, 1 month / 3 months | −0.8% / +11.0% |
| Return, 1 year / 3 years | +20.2% / +95.6% |
| Trend | Uptrend |
| RSI (14) | 51 |
| Volatility (1 year) | 17.7% |
| Worst drawdown (1 year) | -12.7% |
| Average daily value traded | 0.87M NOK |
| Dividend yield | 6.3% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
SpareBank 1 SMN is a Norwegian savings bank based in Trondheim. It provides banking services to personal customers and to small and medium-sized businesses, including deposits, loans, mortgages, insurance and savings products, along with payment and card services. The bank also offers investment and advisory services through its securities arm and works with other members of the SpareBank 1 alliance on shared products and branding. Its main market is central Norway, where it operates a network of local branches.
Sparebank 1 SMN trades under the code 0IVM on the London Exchange in UK, with its price quoted in Norwegian kroner (NOK). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Sparebank 1 SMN (0IVM) trades on the London Exchange in UK. It last closed at NOK 214.35 on 23 October 2026.
Its price-based Market X-Ray is 76 out of 100 (a strong price profile), ranking 220 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 20.2% and over the last three months it rose 11.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 77 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 7.7% | ||
| From 52-week high | -3.0% | ||
| Momentum | 70 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 11.0% | ||
| 6-month return | 4.1% | ||
| 12-month return, skipping the last month | 21.1% | ||
| Stability (higher is calmer) | 91 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 17.7% | ||
| Worst drawdown, 1 year (smaller is calmer) | -12.7% | ||
| Liquidity | 51 · Fair | Moderate trading activity. | |
| Average daily value traded | 0.87M NOK | ||
| Zero-volume days | 11.7% | ||
| Income | 85 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 6.3% | ||
| Years with dividends | 6 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Income: Dividend is high and has been paid regularly.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | −1.1% |
|---|---|
| 1 month | −0.8% |
| 3 months | +11.0% |
| 6 months | +4.1% |
| 1 year | +20.2% |
| 3 years | +95.6% |
| 5 years | +108.1% |
Signals
| 50-day / 200-day average | 212.99 / 199.04 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 10.50 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 27 Mar 2026 | NOK 13.5000 |
| 21 Mar 2025 | NOK 12.5000 |
| 22 Mar 2024 | NOK 12.0000 |
| 29 Mar 2023 | NOK 6.5000 |
| 25 Mar 2022 | NOK 7.5000 |
| 2 Nov 2021 | NOK 3.1000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.